Male/female adults
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Healthy males and females aged 30 to 59 years old when informed consent. 2. Subjects who can give informed consent to partake in this research, after being provided with an explanation of the protocol detail.
Exclusion criteria
Exclusion criteria: 1. Subjects who are in the habit of smoking. 2. Subjects who are receiving medication due to treatment of disease at the time of consent. 3. Subjects who have taken or applied medication for the treatment of any diseases. within the past month (excluding the common cold, but including treatment for hay fever). 4. Subjects who have undergone surgery in the area to be treated (including neck, face, and crown of the head) within the past six months. 5. Subjects currently participating in another clinical trial or those who have participated in a clinical trial within the past month. 6. Subjects who have previous and/or current medical history of serious disease in liver, kidney, heart, lung and/or blood. 7. Females who are pregnant or lactating, and females who could become pregnant or lactating during test period. 8. Subjects who have symptom of dermatologic disease such as atopic dermatitis. 9. Others who have been determined ineligible by investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The autonomic nervous system (Pupil measurement (pupillary light reflex), Vascular age assessment.) | — |
Secondary
| Measure | Time frame |
|---|---|
| The central nervous system (brain age assessment, flicker measurement, postural sway assessment) Psychological questionnaires (SCL30, VAS, Multiple measurements of emotion using a multiple mood scale (40 questions)) | — |
Countries
Japan
Contacts
Share Co.Ltd Representative of Director